Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Automated Diabetes-Control Test

By HospiMedica staff writers
Posted on 16 Jun 2003
A new assay for hemoglobin-A1C (HbA1C) enables a full panel of diabetes-control tests to be consolidated on the same automated analyzer.

HbA1C measurements, used in monitoring the long-term care of diabetics, indicate the average amount of glucose in a patient's blood over the last three months. More...
The HbA1C goal for patients is less than 7%. A major study has shown that patients who keep their HbA1C levels close to 7% have a much better chance of delaying or preventing diabetes-related problems that affect the eyes, kidneys, and nerves.

The new assay measures HbA1C and total hemoglobin concentration in whole blood samples and automatically reports the percentage of HbA1C, freeing laboratory staff from the need to calculate this manually. The assay is the product of Bayer Diagnostics (Tarrytown, NY, USA) and can be run in random access mode on the company's Advia 1650 analyzer together with all other analytes on the system. All reagents, supplied in liquid-stable format ready for use, remain stable for 30 days. Use of microvolume technology results in higher reagent efficiency.

Other diabetes-control tests available on the Advia include glucose, urinary micro-albumin, urinary protein, and serum and urinary creatinine. Use of the complete panel avoids the need to split diabetes testing between multiple laboratory instruments.




Related Links:
Bayer Diagnostics

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical-Grade Display
HL2316SHTB
Medical Adhesive
MED 5570U
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.